| 9/25/2023 | DD | Athenex’s Chapter 11 plan of liquidation effective as of Sept. 22
|
| 9/18/2023 | DD | Athenex receives post-confirmation exclusivity extension
|
| 9/13/2023 | DD | Athenex receives confirmation of Chapter 11 plan
|
| 9/11/2023 | DD | Athenex eyes extension of exclusive plan filing, solicitation periods
|
| 9/7/2023 | DD | Athenex’s Chapter 11 plan accepted by class of unsecured claimholders
|
| 8/24/2023 | DD | Athenex creditors committee and lenders reach global settlement
|
| 8/9/2023 | DD | Athenex closes $14.67 million pharmaceutical asset sale to Oaktree
|
| 8/1/2023 | DD | Athenex receives interim approval of disclosure statement
|
| 7/27/2023 | DD | Athenex files Chapter 11 plan and disclosure statement
|
| 7/10/2023 | DD | Athenex closes sale of Orascovery business to C-MER
|
| 7/5/2023 | DD | Athenex reports $1.74 million net loss for May
|
| 7/3/2023 | DD | Athenex closes sale of pharmaceutical division to Sagent
|
| 6/27/2023 | DD | Athenex gets court approval to sell assets to Sagent, Oaktree
|
| 6/23/2023 | DD | Athenex names winning bidders for pharmaceutical division assets
|
| 6/22/2023 | DD | Athenex receives court approval to sell Orascovery business to C-MER
|
| 6/16/2023 | DD | Athenex receives final court approval to access cash collateral
|
| 6/14/2023 | DD | Athenex Pharma Solutions debtor eyes approval of Almirall settlement
|
| 6/7/2023 | DD | Athenex: Court approves C-MER as stalking horse, moves sale timeline
|
| 6/6/2023 | DD | Athenex lines up stalking horse deal with C-MER Specialty Group
|
| 5/23/2023 | DD | Athenex gets approval of bid procedures; auction set for June 15
|
| 5/19/2023 | BKCVDDEMHY | Prospect News reports eight new defaults for May 11-May 17
|
| 5/17/2023 | DD | Athenex receives interim approval to access cash collateral
|
| 5/15/2023 | BKDD | Athenex files Chapter 11 bankruptcy, hopes to close sale by July 1
|
| 4/13/2023 | DDPV | Biomed offers to buy Athenex after loan default with Oaktree
|
